Acurx Pharmaceuticals Financials - Benzinga

Acurx Pharmaceuticals Inc

ACXPNASDAQ

Trade with Public

Trade with Public

$1.47

-0.06-3.92%

At close: Aug 11, 5:00 PM EST

$1.59

0.128.16%

After Hours: 9:28 AM EST

Earnings: Q2 2026 Earnings in 3 days from now on Fri Aug 14th, before the market open

Conference Call: Conference call scheduled in 3 days at 8:00 AM

Click to view the webcast

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Stock Report

Acurx Pharmaceuticals Financials

Acurx Pharmaceuticals (ACXP) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

What's Going On With Acurx Pharmaceuticals Stock Today?

Acurx Pharmaceuticals (NASDAQ:ACXP) shares down on Friday after reporting net loss for Q4 2025, but with positive cash and $1.5M raised.

Nabaparna Bhattacharya

Earnings Scheduled For March 13, 2026

Benzinga Insights

PRO
Acurx Pharmaceuticals Q4 EPS $(0.73) Beats $(1.65) Estimate

Acurx Pharmaceuticals (NASDAQ:ACXP) reported quarterly losses of $(0.73) per share which beat the analyst consensus estimate of $(1.65) by 55.62 percent. This is a 78.53 percent increase over losses of $(3.40) per share

Benzinga Newsdesk

PRO
Acurx Pharmaceuticals Q3 EPS $(1.23) Beats $(1.31) Estimate

Acurx Pharmaceuticals (NASDAQ:ACXP) reported quarterly losses of $(1.23) per share which beat the analyst consensus estimate of $(1.31) by 6.11 percent. This is a 64.35 percent increase over losses of $(3.45) per share

Benzinga Newsdesk

Earnings Scheduled For November 12, 2025

Benzinga Insights

PRO
Acurx Pharmaceuticals Q2 EPS $(1.89) Up from $(5.21) YoY

Acurx Pharmaceuticals (NASDAQ:ACXP) reported Q2 EPS $(1.89) Up from $(5.21) YoY

Benzinga Newsdesk